Form 8-K - Current report:
SEC Accession No. 0001213900-25-065353
Filing Date
2025-07-18
Accepted
2025-07-18 08:41:17
Documents
14
Period of Report
2025-07-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0249478-8k_rafael.htm   iXBRL 8-K 37200
2 RAFAEL HOLDINGS, INC. FOURTH AMENDED AND RESTATED BY-LAWS (AS AMENDED ON JULY 14 ea024947801ex99-1_rafael.htm EX-99.1 81351
  Complete submission text file 0001213900-25-065353.txt   350326

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE rfl-20250714.xsd EX-101.SCH 3779
4 XBRL DEFINITION FILE rfl-20250714_def.xml EX-101.DEF 26620
5 XBRL LABEL FILE rfl-20250714_lab.xml EX-101.LAB 36675
6 XBRL PRESENTATION FILE rfl-20250714_pre.xml EX-101.PRE 25244
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0249478-8k_rafael_htm.xml XML 5676
Mailing Address 520 BROAD STREET NEWARK NJ 07120
Business Address 520 BROAD STREET NEWARK NJ 07120 212-658-1450
Rafael Holdings, Inc. (Filer) CIK: 0001713863 (see all company filings)

EIN.: 822296593 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-38411 | Film No.: 251132675
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)